<Disease><Name>BRUNNER SYNDROME (MONOAMINE OXIDASE-A DEFICIENCY (MAO-A)</Name><Synonym>MONOAMINE OXIDASE-A DEFICIENCY (MAO-A)</Synonym><OMIM><Number>300615</Number><URL>http://omim.org/entry/300615</URL></OMIM><Orphanet><Number>3057</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=3057</URL></Orphanet><Protein><Number>Amine oxidase [flavin-containing] A</Number><URL>http://www.uniprot.org/uniprot/P21397</URL></Protein><ExPASy><Number>1.4.3.4</Number><URL>http://enzyme.expasy.org/EC/1.4.3.4</URL></ExPASy><Gene>Xp11.23</Gene><ICD>E70.8</ICD><Summary>rare ;X-linked recessive;Brunner syndrome; should be considered as a cause of mild ID with paroxysmal behavioural symptoms [Palmer EE, 2016]</Summary><Symptoms><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1952</id><symptom>behavior, self-mutilating or destructive / behaviour, self-mutilating or destructive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3163</id><symptom>hand movements, abnormal, stereotyped</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1702</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.00</min><max>3.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1751</id><name>Tyramine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>86.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>2128</id><name>3-Methoxytyramine</name><specimen>urine</specimen><value>increased</value><min>45.00</min><max>480.00</max><unit>&#181;mol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>2129</id><name>3-Methoxytyramine</name><specimen>urine</specimen><value>increased</value><min>60.00</min><max>145.00</max><unit>&#956;mol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>669</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.10</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>671</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.30</min><max>11.50</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>670</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>12.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>672</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.00</min><max>13.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>673</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal/dec</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>194</id><name>Tyramine</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>low</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6516</id><title>Gene-environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions</title><author>Nilsson KW,</author><journal>J Neural Transm (Vienna)</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6517</id><title>From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency</title><author>Bortolato M,</author><journal>J Neural Transm (Vienna)</journal><year>2018</year><book /><volume>125</volume><number>11</number><pages>1589-1599</pages><co_aut>Floris G, Shih JC</co_aut></literature><literature><id>4797</id><title>New insights into Brunner syndrome and potential for targeted therapy</title><author>Palmer EE,</author><journal>Clin Genet</journal><year>2016</year><book /><volume>89</volume><number>1</number><pages>120-127</pages><co_aut>et al.</co_aut></literature><literature><id>6518</id><title>Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry</title><author>Marcos J,</author><journal>J Chromatogr A</journal><year>2016</year><book /><volume>1434</volume><number>0</number><pages>91-101</pages><co_aut>et al.</co_aut></literature><literature><id>4798</id><title>20 ans apr&#232;s: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior an</title><author>Piton A,</author><journal>Eur J Hum Genet</journal><year>2014</year><book /><volume>22</volume><number>6</number><pages>776-783</pages><co_aut>et al.</co_aut></literature><literature><id>2271</id><title>Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment</title><author>Haberstick BC</author><journal>Am J Med Genet B Neuropsychiatr Genet</journal><year>2005</year><book /><volume>135</volume><number>1</number><pages>59-64</pages><co_aut>et al.</co_aut></literature><literature><id>2270</id><title>Role of genotype in the cycle of violence in maltreated children</title><author>Caspi A</author><journal>Science</journal><year>2002</year><book /><volume>297</volume><number>0</number><pages>851-854</pages><co_aut>et al.</co_aut></literature><literature><id>690</id><title>Disorders of neurotransmitter metabolism</title><author>Hyland K</author><journal>Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman &amp; Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>79-98</pages><co_aut>et al.</co_aut></literature><literature><id>1021</id><title>Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA</title><author>Cases O</author><journal>Science</journal><year>1995</year><book /><volume>268</volume><number>0</number><pages>1763-1766</pages><co_aut>et al.</co_aut></literature><literature><id>1019</id><title>Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A</title><author>Brunner HG</author><journal>Science</journal><year>1993</year><book /><volume>262</volume><number>0</number><pages>578-580</pages><co_aut>et al.</co_aut></literature><literature><id>1020</id><title>X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for </title><author>Brunner HG</author><journal>Am J Hum Genet</journal><year>1993</year><book /><volume>52</volume><number>0</number><pages>1032-1039</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>